The one year survival rate in group A(16.7%) was lower than that in group B(40.0%) . Conclusion The general SCLC chemotherapy regimen is suitable for NSCLC patients with high serum NSE level.

 
  • 1年生存率40.;0%25;兩組差異有顯著(zhù)(P<0
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan